| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441106 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
CAPOX is associated with significantly more grade III-V toxicities than CapMono, which had a pronounced impact on the cumulative dosage received and completion of all planned cycles. In this light, CapMono seems preferable over CAPOX.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
F.N. van Erning, L.G.E.M. Razenberg, V.E.P.P. Lemmens, G.J. Creemers, J.F.M. Pruijt, H.A.A.M. Maas, M.L.G. Janssen-Heijnen,